Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0534 Transporter Info | ||||
Gene Name | CACNA1C | ||||
Transporter Name | Voltage-gated calcium channel alpha Cav1.2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Bone | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CACNA1C gene in brain neuroblastoma condition | [3] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human neuroblastoma cells (SH-SY5Y) | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) has been reported to activate the transcription of CACNA1C gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
FOSL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [4] | ||||
TF Protein Name |
Fos-related antigen 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Fos-related antigen 1 (FOSL1) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
NFE2L2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of CACNA1C gene in colon cancer condition | [5] | ||||
TF Protein Name |
Nuclear factor erythroid 2-related factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human colon carcinoma cells (RKO) | |||||
Detailed Description |
Nuclear factor erythroid 2-related factor 2 (NFE2L2) has been reported to repress the transcription of CACNA1C gene in colon cancer condition, which leads to a decreased expression of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
ARNT |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [6] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Tissue |
Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [4] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
EPAS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [6] | ||||
TF Protein Name |
Endothelial PAS domain-containing protein 1 | Transcription Factor Info | ||||
Tissue |
Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Endothelial PAS domain-containing protein 1 (EPAS1) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CACNA1C gene in brain neuroblastoma condition | [3] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human neuroblastoma cells (SH-SY5Y) | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to activate the transcription of CACNA1C gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [1] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [4] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
PPARG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [1] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor gamma | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Peroxisome proliferator-activated receptor gamma (PPARG) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [2] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
EGR2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [2] | ||||
TF Protein Name |
E3 SUMO-protein ligase EGR2 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
E3 SUMO-protein ligase EGR2 (EGR2) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [6] | ||||
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [6] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [4] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [1] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
PBX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [4] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [2] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [6] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [1] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Embryo; Liver; Lung; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
ELK3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [6] | ||||
TF Protein Name |
ETS domain-containing protein Elk-3 | Transcription Factor Info | ||||
Tissue |
Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS domain-containing protein Elk-3 (ELK3) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
ETV1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [4] | ||||
TF Protein Name |
ETS translocation variant 1 | Transcription Factor Info | ||||
Tissue |
GastroIntestine tract; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS translocation variant 1 (ETV1) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [1] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [2] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Liver; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [2] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [1] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
Class 3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
KDM5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene | [6] | ||||
TF Protein Name |
Lysine-specific demethylase 5B | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Lysine-specific demethylase 5B (KDM5B) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
Class 6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFAT5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of CACNA1C gene in health condition | [7] | ||||
TF Protein Name |
Nuclear factor of activated T-cells 5 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Heart | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Mouse embryo cardiomyocyte cells (P19cl6) | |||||
Detailed Description |
Nuclear factor of activated T-cells 5 (NFAT5) has been reported to activate the transcription of CACNA1C gene in health condition, which leads to an increased expression of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
Class 10.1: Other factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ZNF804A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to CACNA1C gene in bipolar affective disorder condition | [8] | ||||
TF Protein Name |
Zinc finger protein 804A | Transcription Factor Info | ||||
Studied Phenotype |
Bipolar affective disorder [ICD11: 6A60] | |||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Experimental Material |
human peripheral blood mononuclear cell isolates | |||||
Detailed Description |
Zinc finger protein 804A (ZNF804A) can directly bind to the CACNA1C gene, which in turn affects the expression or function of the drug transporter Voltage-gated calcium channel alpha Cav1.2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.